This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Aplidin - Dexamethasone in Relapsed/Refractory Mye...
Clinical trial

Aplidin - Dexamethasone in Relapsed/Refractory Myeloma (ADMYRE)

Read time: 2 mins
Last updated:1st Jun 2010
Identifier: NCT01102426

Study of Plitidepsin in combination with dexamethasone versus dexamethasone alone in patients with relapsed/refractory multiple myeloma.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Randomized, Multicenter, Open-label, Phase III Study of Plitidepsin in Combination With Dexamethasone vs. Dexamethasone Alone in Patients With Relapsed/Refractory Multiple Myeloma
Estimated Enrollment: 250
Study Start Date: June 2010
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)

- Experimental:
Arm A
- Active Comparator: Arm B

Category Value
Date last updated at source 2017-09-25
Study type(s) Interventional
Expected enrolment 250
Study start date 2010-06-01
Estimated primary completion date 2017-11-01

View full details